Australia is currently experiencing significant and ongoing shortages of several ADHD medications, particularly methylphenidate hydrochloride products such as Concerta, Teva-XR, Ritalin, Artige, and Ritalin LA. These disruptions are having real impacts on children, families, and prescribers across the country.

Why There Is a Shortage
Global manufacturing issues are the core cause — impacting multiple countries, not just Australia.
Australia is at the end of the global supply chain, importing 90% of its medication but only making up 2% of the global demand — making us more vulnerable.
Increased demand for ADHD medication in recent years, driven by greater awareness and diagnosis rates, is outpacing supply.
Pharmaceutical companies Janssen-Cilag, Teva Pharma, and Novartis have all reported delays or low availability of key ADHD medications.
How Long We Can Expect to Wait
Concerta modified-release tablets (18mg, 27mg, 36mg, 54mg) are expected to remain in limited supply until at least the end of May 2025, with some ongoing shortages possibly lasting through to December 2025.
Teva-XR and Ritalin LA are also affected, with no firm resolution dates.
Immediate-release formulations like Ritalin and Artige 10mg are also delayed as of April 2025.
Is There Anything Currently Being Done to Acquire More Stock?
The Therapeutic Goods Administration (TGA) is:
Approving overseas-registered versions of Concerta under Section 19A of the Therapeutic Goods Act 1989 to ease pressure on supply.
Monitoring supply chains and working directly with pharmaceutical companies to manage shortages.
Pharmacists can order overseas alternatives through Medsurge Healthcare (1300 788 261) using existing prescriptions.
These overseas options are not PBS-subsidised, which may result in higher out-of-pocket costs.
What We Can Do to Help Us When We Can’t Get the Medication
Speak with your pharmacist early — they’ll have the most up-to-date info on what's available and how to access alternatives.
If offered an overseas-registered product:
Check for any differences (e.g. packaging, pill size, or name).
Be aware that costs may be higher, and new prescriptions may be required in some cases.
Overseas approval orders information can be found here. https://www.tga.gov.au/resources/section-19a-approvals
Talk to your doctor about:
Temporary alternative medications or formulations (e.g. short-acting versions).
Adjusting dosages or trialing other stimulant or non-stimulant treatments.
Build a strong relationship with your pharmacy — this helps in managing substitutions and staying informed about stock changes.
Speak to your child's school now about the possibility of medication being unavailable and what you can collaborate together to support your child through this time within the school setting. It's better to be prepared, than dealing with it during the chaos.
Remember: ADHD treatment is not just medication. Support strategies like behaviour management, routine building, diet, sleep hygiene, and educational supports are just as important during times of medication disruption. For more information please visit, https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products